physician practices

Views & Analysis

The ongoing COVID-19 pandemic has affected the routines of many practicing physicians, including an impact on their prescribing decisions.

News

Intellia has reported the first-ever phase 3 results with an in vivo gene-editing therapy, CRISPR-based lonvo-z for hereditary angioedema.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.